Explore tweets tagged as #Target2Patient
Interesting listening to @SteveRees16 talk on the approach AstraZeneca take to identifying new drug targets through AI and multiomics. Promising times for CKD! #target2patient
0
1
3
🔊 Join industry leaders at #Target2Patient, 8-10 May, to find out how scientific advances are enabling the identification of novel drug targets, and new medicines to treat and cure disease. 🐦Early bird registration ends soon https://t.co/VYfa5ixyFM
#genomics #bioinformatics
0
11
22
Registration is now open for the #Target2Patient Conference (8-11 May). Find out from industry leaders how advances in #genomics, #digitalhealth & #bigdata are being used to identify new drug targets and improve clinical trials. https://t.co/VYfa5iy6vk
2
5
17
Next up is @emblebi's own @ewanbirney discussing using #genetics to understand human biology at #Target2Patient
1
0
2
Save the date for #Target2Patient Conference 2024! The latest on advances in #genomics, in vitro technologies, #AIML and digital health for drug development. 📆 29-30 April 2024 Register your interest: https://t.co/IrspXqRpDW
2
3
5
4 weeks and counting until #Target2Patient 2024, and we are delighted to welcome our new event sponsor @UltimaGenomics. In person registration closes 15 April 2024: https://t.co/lyA3AQJ4A3
#drugdiscovery #genomics #invitro technologies #AIML #digitalhealth #drugdevelopment
1
1
8
Introducing our keynote speakers at #Target2Patient, 29 – 30 April 2024: Dr Melanie Lee CBE, and Professor Sir Munir Pirmohamed @MPUoL. Early bird registration is open until 26 February: https://t.co/hynQZcEXfD
#genomics, #invitro technologies, #digitalhealth #drugdevelopment
1
2
5
Thank you to everyone who joined in today at #Target2Patient. We’ll be back tomorrow for day two, both at @HinxtonHall and online.
1
1
4
Early bird registration is now open for #Target2Patient 2024. Join us at @HinxtonHall, or online, to hear about the latest advances in #genomics, in vitro technologies, #AIML and digital health for drug development. 📆 29-30 April 2024 https://t.co/C9ezgsKCMZ
1
6
13
Victor Neduva @MSDintheUK takes to the stage now to present his work on novel target discovery in #neuroscience at #Target2Patient
1
1
4
@emblebi @ewanbirney @EMBLHeidelberg Session three focusses on #bioinformatics and #BigData at #Target2Patient. 🗣️ It continues now with James Pilling from @ASTRAZENECAUK introducing the work of the @broadinstitute JUMP-CP consortium on morphological profiling.
1
5
7
@emblebi @ewanbirney @EMBLHeidelberg @ASTRAZENECAUK @broadinstitute @plinkyplink @AstraZeneca Our final speaker for #Target2Patient session three is Michael Johnson @imperialcollege detailing his work on #singlecell Mendelian randomisation for target discovery in brain disease.
1
2
5
@HinxtonHall @emblebi @AstraZeneca @ARUKnews @ucl @NPL @sangerinstitute @FBMH_UoM @OfficialUoM @pfizer @RuthMcKernan That's a wrap! It started with an idea four years ago. Delayed by the pandemic, but now completed, it was certainly worth the wait. A big thank you to the venue, sponsors, organisers, speakers, and the audience both in-person & virtually that has joined us for #Target2Patient!
2
4
11
@HinxtonHall 🧑💼The #Target2Patient hybrid poster session is now live! Delegates can talk to poster authors either in person at @HinxtonHall or online via https://t.co/T86TQ8cajM
1
0
3
@HinxtonHall @emblebi @AstraZeneca @ARUKnews @ucl @NPL @sangerinstitute Session four is underway now at #Target2Patient beginning with Darren Plant from @FBMH_UoM speaking remotely. The session is focused on appropriate patients in the right trials. 🗣️Darren is presenting his work on the search for reliable #biomarkers.
1
1
5
Up next we have @SteveRees16 from @ASTRAZENECAUK showcasing his work on turning novel target hypotheses into #drugdiscovery projects. #Target2Patient
1
0
5
@MenePangalos from @AstraZeneca gives the opening keynote at the #Target2Patient meeting in Cambridge discussing how precision medicines can be developed for chronic diseases outside of Oncology. Great examples in Heart Failure, COPD and CKD
0
2
2